HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

[Evaluation of subselective intraarterial infusion chemotherapy in far advanced gastric and colorectal cancer].

Abstract
We investigated the usefulness of subselective intraarterial infusion chemotherapy in far advanced gastric and colorectal cancer. Among gastric and colorectal cancer cases undergoing surgery at our hospital for the past ten years, patients with and without palliative resection were studied. Forty gastric cancer patients and 29 colorectal cancer patients were treated by subselective intraarterial infusion chemotherapy. In gastric cancer cases without resection, a significantly longer survival was noted in patients undergoing this therapy with over 5 g of 5-FU than those treated with conventional chemotherapy. In gastric cancer patients with palliative resection and colorectal cancer patients, survival time was longer by intraarterial infusion with over 5 g of 5-FU, but not significant. Partial response was obtained in 5 cases of gastric cancer and 3 cases of colorectal cancer, and clinical symptoms were improved in 44% of the patients. The main complications of this therapy were myelosuppression and occlusion of the catheter, but none of them were serious. For the improved quality of life of cancer patients, subselective intraarterial infusion chemotherapy is considered a safe and useful form of treatment.
AuthorsM Murotani, M Takami, T Fujimoto, T Takada, M Kitada, Y Tsukahara, Y Okumura, M Saito, T Shibata, Y Watanabe
JournalGan to kagaku ryoho. Cancer & chemotherapy (Gan To Kagaku Ryoho) Vol. 20 Issue 11 Pg. 1650-3 (Aug 1993) ISSN: 0385-0684 [Print] Japan
PMID8373239 (Publication Type: English Abstract, Journal Article)
Chemical References
  • Mitomycin
  • Fluorouracil
Topics
  • Antineoplastic Combined Chemotherapy Protocols (therapeutic use)
  • Colonic Neoplasms (drug therapy, mortality)
  • Female
  • Fluorouracil (administration & dosage)
  • Humans
  • Infusion Pumps, Implantable
  • Infusions, Parenteral
  • Middle Aged
  • Mitomycin (administration & dosage)
  • Stomach Neoplasms (drug therapy, mortality)
  • Survival Rate

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: